Dominic S. Raj

<i>APOL1</i> Risk Variants, Race, and Progression of Chronic Kidney Disease

Afshin Parsa, W.H. Linda Kao, Dawei Xie et al. · New England Journal of Medicine · 2013 · 761 citations · Full text

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial

Paul M. Ridker, Matt Devalaraja, Florian M.M. Baeres et al. · The Lancet · 2021 · 596 citations

Inflammation, Anti-inflammatory, Cardiovascular Disease +10

Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC

Jayanta Gupta, Nandita Mitra, Peter A. Kanetsky et al. · Clinical Journal of the American Society of Nephrology · 2012 · 580 citations · Full text

Fibroblast Growth Factor-23 and Cardiovascular Events in CKD

Julia J. Scialla, Huiliang Xie, Mahboob Rahman et al. · Journal of the American Society of Nephrology · 2013 · 425 citations · Full text

Inflammation and Progression of CKD: The CRIC Study

Richard Amdur, Harold I. Feldman, Jayanta Gupta et al. · Clinical Journal of the American Society of Nephrology · 2016 · 423 citations · Full text